Prefer to watch it first? See the value chain in motion →

Axioma Strategy · Value Chain Innovation

The Hidden Friction Engine in Biopharma

Most delay in biopharma is not scientific — it is operational. Michael applies customer-experience discipline inside the enterprise, turning internal drag into frictionless flow so therapies reach patients faster.

Explore the Value Chain Request an Assessment
The Enterprise Value Chain

Five Stages, One Continuous Loop

Enterprise CX applies the discipline of customer experience inward — treating every handoff between functions as a service to be designed, measured and improved, rather than a boundary where work piles up and waits.

Why it matters: every week removed from the value chain is a week sooner a therapy reaches the patients who need it. Frictionless operations do not just protect margin — they save and improve lives.

Switch between how work moves today and how it moves once Enterprise CX is applied, then select any stage for the executive detail.

Sequential handoffs, redundant approvals and siloed systems. Work stops and restarts at every boundary, and hard-won insight rarely travels back upstream.

Every boundary is designed as a service. Work flows forward and evidence flows back — a continuous loop, not a relay race.

Continuous feedback — field signal, real-world evidence and access data flow back upstream to sharpen every earlier stage. One-way handoffs — downstream learning rarely reaches the teams who could act on it, so the same problems recur.
Target & Portfolio Strategy

Portfolio prioritization, indication selection & early asset triage

Where value drags today

Siloed R&D and commercial priorities push portfolio decisions to be optimized asset-by-asset, not enterprise-wide.

The frictionless path

An enterprise service blueprint mapping decision rights and value hand-offs across R&D, medical, and commercial before assets enter development.

What to measure
Late-stage reversals
Portfolio decisions overturned after assets enter development
Clinical Development & Ops

Trial design, site activation & CRO / vendor orchestration

Where value drags today

Redundant approval loops between clinical, regulatory, and data management stretch trial activation timelines.

The frictionless path

A journey-mapped activation workflow with parallel-path approvals and a single accountable owner per milestone.

What to measure
Activation cycle time
Elapsed time from site selection to site activation
Medical & Regulatory

Evidence generation, HEOR & regulatory submissions

Where value drags today

Regulatory and medical evidence is built independently of market-access requirements, forcing costly rework.

The frictionless path

A shared evidence framework that aligns regulatory submissions with payer and HTA needs from day one.

What to measure
Evidence rework
Rework caused by evidence misaligned with payer and HTA needs
Commercial & Field Execution

Launch planning, sales enablement & field messaging

Where value drags today

Sales and marketing operate on separate systems and calendars, diluting launch messaging at the point of care.

The frictionless path

A unified launch operating model with shared KPIs and a single content and insight source for field and marketing.

What to measure
Launch alignment
Consistency of message and KPIs between sales and marketing
Access & Patient Operations

Patient services, hub operations & payer contracting

Where value drags today

Patient-support handoffs between hub, specialty pharmacy, and payer teams create access delays.

The frictionless path

End-to-end patient-journey orchestration with real-time visibility across hub, pharmacy, and access teams.

What to measure
Time-to-therapy
Elapsed time from patient enrollment to therapy start

Each stage is paired with the measure an engagement would track. Baselines and targets are set with the client, not assumed in advance.

Methodology

Powered by Structured Applied Creativity

The approach pairs hard operational data with structured creative facilitation — a repeatable, evidence-based problem-solving discipline, not a one-off workshop. Teams deliberately diverge to explore before they converge to decide, deferring judgment so the real problem gets solved rather than the obvious symptom.

And it runs as a cycle, not a line. Every solution reshapes the system and surfaces the next opportunity — so improvement compounds engagement after engagement.

01 — Generate
Find and frame the real problem — problem, fact and definition finding
02 — Conceptualize
Open a wide field of ideas before narrowing to the strongest
03 — Optimize
Evaluate, select and plan against cost, risk and speed
04 — Implement
Win acceptance and put the solution into action with the teams who own it
Each cycle surfaces the next problem — the process repeats, and improvement compounds.
Executive Diagnostic

Map Your Internal CX Friction

Request an executive diagnostic session directly with Michael.

This form is for inquiries from biopharma organizations about a specific decision or engagement. Vendor and service solicitations will not receive a response.

Request received.

Michael will follow up personally within two business days.

If you do not hear back, please email inquiries@axiomastrategy.com.

Request Strategic Assessment